DFP-treated MDS mice exhibit increased Hb and RBC count relative to untreated MDS mice and no change in MCV or reticulocytosis (Figure 2A–D); both male and female mice demonstrate approximately equivalent responses to DFP (Figure 2—figure supplement 1). This evidence concerns the gene GSTM1 and myelodysplastic syndrome.